Oncology Diagnostics Panel Session

Ex-US Opportunities and Limitations explores the landscape outside of the US with a focus on larger markets such as China and India. The panelists share their perspective on what the US can learn from these developing markets as well as why the maturation process takes significant time and effort.


  • Shailesh Maingi – Founder and CEO, Kineticos

Panel Members

  • Eric Mayer – CEO, EDP Biotech
  • Sandra Dunn – CEO, Phoenix Molecular
  • Brian Kelly – Global Director, Diagnostic Partnering, Thermo Fisher

Subscribe to Kineticos to receive weekly emails containing insightful content.